Status:
COMPLETED
Obstetric and Perinatal Outcomes of Women With COVID-19
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Pregnant Women
Eligibility:
FEMALE
18+ years
Brief Summary
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently spreading rapidly around the globe, causing a major public health issue. There is currently very few data about the impact of ...
Detailed Description
Clinical manifestations of COVID-19 can range from a benign upper respiratory tract infection to severe acute respiratory distress syndrome (ARDS), fatal in 1% of cases. However, pregnant women and th...
Eligibility Criteria
Inclusion
- Pregnant women
- Able to give informed consent
- Diagnosed with COVID-19
Exclusion
- Patients Refusing to Participate in the Study
- Patients who do not speak French well enough to benefit from clear and intelligible information
Key Trial Info
Start Date :
April 23 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 15 2022
Estimated Enrollment :
556 Patients enrolled
Trial Details
Trial ID
NCT04369859
Start Date
April 23 2020
End Date
January 15 2022
Last Update
February 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hôpitaux de Marseille
Marseille, PACA, France, 13354